US Bancorp’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $869 | Sell |
62
-57
| -48% | -$799 | ﹤0.01% | 3958 |
|
2025
Q1 | $1.86K | Buy |
119
+95
| +396% | +$1.49K | ﹤0.01% | 3881 |
|
2024
Q4 | $334 | Buy |
+24
| New | +$334 | ﹤0.01% | 4044 |
|
2023
Q3 | – | Sell |
-80
| Closed | -$762 | – | 3960 |
|
2023
Q2 | $762 | Buy |
+80
| New | +$762 | ﹤0.01% | 3801 |
|
2023
Q1 | – | Sell |
-480
| Closed | -$7.1K | – | 4060 |
|
2022
Q4 | $7.1K | Buy |
480
+428
| +823% | +$6.33K | ﹤0.01% | 3388 |
|
2022
Q3 | $1K | Sell |
52
-233
| -82% | -$4.48K | ﹤0.01% | 3889 |
|
2022
Q2 | $6K | Hold |
285
| – | – | ﹤0.01% | 3483 |
|
2022
Q1 | $5K | Buy |
+285
| New | +$5K | ﹤0.01% | 3565 |
|
2021
Q4 | – | Sell |
-114
| Closed | -$3K | – | 4051 |
|
2021
Q3 | $3K | Buy |
114
+22
| +24% | +$579 | ﹤0.01% | 3726 |
|
2021
Q2 | $3K | Buy |
+92
| New | +$3K | ﹤0.01% | 3685 |
|